Avid Bioservices Inc (CDMO)

[entdoc]

zumantu: FAB. Absolutely fabulous. "We would like to pay tribute to the late Dr. Philip Thorpe (at UTSW, and PPHM). "We thank Peregrine Pharmaceuticals Inc., Tustin, CA, for the provision of PGN635 antibody." Truly another "turning point in the treatment of the devastating brain tumor glioblastoma multiforme, GBM. This is one of the factors that keeps me aboard here. Thank you for the reference. As I've posted here numerous times, Bavi for the tumor vasculature, and Cotara for the tumor center. That combination makes sense. When will it come to that? I curse the day PPHM had to choose chemotherapy to add Bavi to, and immune-oncology as a standard-bearer. I-O is mostly a hoax that makes no sense. Pursuing Bavi's affinity to blood vessels that feed cancer cells does make sense. Bali coupled with nanoparticles is sensible. Coupling Bavi with an agent like Cotara that penetrates to tumor center and kills core cancer cells makes all the sense in the world. Now we are getting somewhere.